Skip navigation
HKU Login
Guest Login
Home
Publications
Researchers
Staff
Research Postgraduates
Organizations
Grants
Datasets
Deposit Data
HKUL Research Data Management
Theses
Patents
Community Service
Browsing "Department of Clinical Oncology" by Author tseng, lm
Jump to:
0-9
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
中
or enter first few letters:
Showing results 1 to 2 of 2
Title
Author(s)
Issue Date
Analysis of the pan-Asian subgroup of patients in the NALA Trial: a randomized phase III NALA Trial comparing neratinib+capecitabine (N+C) vs lapatinib+capecitabine (L+C) in patients with HER2+metastatic breast cancer (mBC) previously treated with two or more HER2-directed regimens
Journal:
Breast Cancer Research and Treatment
Dai, MS
Feng, YH
Chen, SW
Masuda, N
Yau, T
Chen, ST
Lu, YS
Yap, YS
Ang, PCS
Chu, SC
Kwong, A
Lee, KS
Ow, S
Kim, SB
Lin, J
Chung, HC
Ngan, R
Kok, VC
Rau, KM
Sangai, T
Ng, TY
Tseng, LM
Bryce, R
Bebchuk, J
Chen, MC
Hou, MF
2021
LUX-breast 2: Phase II, open-label study of oral afatinib in HER2-overexpressing metastatic breast cancer (MBC) patients (pts) who progressed on prior trastuzumab (T) and/or lapatinib (L)
Proceeding/Conference:
Journal of Clinical Oncology
Hickish, T
Tseng, LM
Mehta, AO
Tsang, J
Kovalenko, N
Udovitsa, D
Pelling, K
Uttenreuther-Fischer, MM
Huang, CS
LUX-Breast 2 Study Group
2012